Received for publication 24 September 1979 Kolhouse et al., 1978) has cast doubts on their reliability in distinguishing untreated pernicious anaemia from normal. There is thus need to evaluate the methods in current use.
Measurement of vitamin B12 in serum or plasma is a widely performed test for the investigation and management of patients suspected of megaloblastic anaemia, for excluding vitamin B12 deficiency as a cause of high MCV in patients whose blood counts are within the normal range, for screening for possible vitamin B12 neuropathy, and for the investigation of liver and myeloproliferative disease.
For many years the serum vitamin B12 was measured by microbiological assay using Euglena gracilis or Lactobacillus leichmannii, and these methods were used in both routine and reference laboratories. Although it has always been recognised that the techniques are complex and require the use of standard sera, they are precise and reproducible (Mollin et al., 1976) and are consistently able to discriminate vitamin B12 deficiency from normal; they are particularly valuable in the diagnosis of vitamin B12 neuropathy.
The introduction of radioisotope dilution (RID) assays, especially in the form of commercial kits, provided an alternative test with the apparent advantages of being convenient, easy to perform, providing rapid results, and, in contrast to the L. leichmannii assay, not being affected by antibiotic or other drugs in serum. This led to widespread adoption of the isotope techniques. However, the results with the RID assays in general tend to be higher than those with the microbiological assays (Mollin et al., 1976) , and recent work (Hall, 1977; Mahood, 1977; Cooper and Whitehead, 1978;  Received for publication 24 (Chappell and Ward, 1978 (83), and RID by other techniques (43). A small number of laboratories returned results by more than one method. Three participants with special interest in the investigation of megaloblastic anaemias were invited to be reference laboratories. Two of these used the E. gracilis assay as described by Anderson (1964) , the third the L. keichmannii assay (Spray, 1955) .
Results
The results of the five trials are shown in Tables 1-3 . The first trial which was a pilot study was on a single sample of plasma with a normal vitamin B12 content. Participants gave a mean of 423-1 ng/l with a large SD (155-6 ng/l) and CV 36-8% (Table 1 (100 ng/l); 0 = E. gracilis; * = L. leichmannii.
are due not to biological discrepancies but to technical faults in these relatively complex methods which require that every step in the procedure be standardized and strictly adhered to. It should be 250 300
noted that in the reference laboratories both microbiological methods were equally satisfactory.
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The major factor in technical error in microbiological 7rcoal; assay of vitamin B12 is the lack of reference preparations. Thus there is a need for stable and reliable material of known vitamin B12 content which can be utine practice. used to verify the accuracy of the method used in te and repro-routine practice. Preliminary studies have indicated the recovery of that freeze-dried human serum is suitable; it is ,factory. In the necessary to have several preparations obtained from microbiological both normal subjects and patients in order to cover particularly with the clinically relevant range of B12 levels. The more marked vitamin B12 of the sera will need to be measured by one or more reference laboratories using a clearly the discrepant defined method of known reliability with a high rd for vitamin degree of accuracy and precision which can be the results of established as the reference method. The data from over the years the present study, together with many previous biological assay published studies, suggest that microbiological assay fic for vitamin with Euglena can be recommended as the reference ie clinical con-method. biological assay The problem of the RID assay kits is more complicated. Some RID methods have been reported to give higher results than RID charcoal methods (Raven and Robson, 1974) . These higher levels were reported with assays using either R-binder (Green et al., 1974) or intrinsic factor (Wide and Killander, 1971; Raven et al., 1969; Raven et al., 1972; Cooper and Whitehead, 1978) . Pure intrinsic factor (IF) only binds clinically active cobalamin whereas R-binder protein also binds inactive analogues of B12 (Bunge and Schilling, 1958; Kolhouse and Allen, 1977 Green et al. (1974) , and the variable, confusing, and sometimes dangerous results obtained by RID kits claiming to use only IF as their binder (Kolhouse et al., 1978; Cooper and Whitehead, 1978 The parameters necessary for ensuring the precision and specificity of such kits are now under discussion in the United States by the National Committee for Clinical Laboratory Standards (NCCLS). The chick serum assay (R-protein assay) has many technical advantages over RID assays using IF and discriminates patients with pernicious anaemia from controls with considerable consistency (Green et al., 1974) . This suggests that in most instances the level of the suspected B12 analogues and the serum B12 level in pernicious anaemia parallel each other (Sourial and Mollin, 1979) . However, as those authors point out, this assay may fail to discriminate between normals and B12 deficiency in patients in whom B12 deficiency is complicated by folate deficiency and in some patients in whom deficiency is due to conditions other than pernicious anaemia. Whether modifications of the R-binder assay will permit it to discriminate invariably between B12 deficiency and control subjects remains to be determined. 
